Role of TDM-based dose adjustments for major taxane anticancer drugs
M. Muth1, F.W.
Ojara2, C. Kloft2, M.
Joerger1
1Department of Oncology & Hematology, Cantonal
Hospital, St. Gallen, Switzerland, Rorschacherstrasse 95, .Gallen,
Switzerland
2Department of Clinical Pharmacy and Biochemistry,
Institute of Pharmacy, Freie Universitaet Berlin, Germnay